Skip to main content
Navigate Up
Sign In

University of Colorado Denver | Anschutz Medical Campus

University of Colorado Denver, Newsroom

Contact Info

Email Us >

Contact a Specialist >

Submit a Story >

For General Inquiries:

Call 303-724-1520
or Fax 303-724-1521

Address:

The Anschutz Medical Campus,
Building 500, Room CG009
13001 E. 17th Place
Mail Stop F413,
P.O. Box 6508
Aurora, CO 80045-0508

Free screenings for relatives of people with type 1 diabetes

Researchers say type 1 diabetes may be “easier to prevent than to cure”

5/23/2012
Diabetes blood test


By Jackie Brinkman | University Communications

AURORA, Colo. – Researchers at the Barbara Davis Center for Diabetes at the University of Colorado Anschutz Medical Campus are offering free screenings to relatives of people with type 1 diabetes whose chances of developing the disease are 15 times greater than those with no family history. 

Type 1 Diabetes TrialNet, an international network of researchers exploring ways to prevent and delay the progression of type 1 diabetes, has reached an important milestone: screening 100,000 people. This is a major achievement because it has helped researchers better predict who will develop diabetes and when it will require treatment. Earlier diagnosis helps patients avoid a severe, life-threatening condition called diabetic ketoacidosis.

TrialNet researchers are currently conducting two prevention studies for at-risk relatives of people with type 1 diabetes:

  • The Anti-CD3 Prevention Study is testing whether an experimental drug called teplizumab can prevent or delay type 1 diabetes. In previous studies, teplizumab helped preserve insulin production in newly diagnosed individuals.
  • The Oral Insulin Prevention Study is testing whether one daily insulin capsule (taken by mouth) can prevent or delay type 1 diabetes. Results of a previous NIH study indicated oral insulin might delay type 1 diabetes for up to 10 years in individuals with certain autoantibodies.  

“We believe diabetes may be easier to prevent than to cure” said Dr. Peter Chase professor of Pediatrics at CU School of Medicine and director of the Pediatric Clinic, Emeritus at the Barbara Davis Center for Diabetes. “Screening provides an important opportunity for intervention at an early stage.”

Incidence of type 1 diabetes is rapidly increasing worldwide. The disease also is presenting at an earlier age, with the greatest increase in children under age five. Each year, in the U.S. alone, approximately 15,000 children and adolescents are diagnosed with type 1 diabetes. While peak ages for diagnosis are between 11 and 14, type 1 diabetes can occur at any age. 

Unlike type 2 diabetes, which may be controlled and even prevented with diet and exercise, there’s currently no cure for type 1 diabetes, an autoimmune condition requiring lifelong insulin injections.

For an appointment for free screening (ages 1-45 years) for the risk of developing type 1 diabetes please call the Barbara Davis Center, Aurora Colorado at: (800) 572-3992.

TrialNet is funded by the National Institutes of Health. Nearly 200 TrialNet locations nationwide offer free screenings and prevention studies. Screening test kits are also available by mail.

To learn more, visit www.DiabetesTrialNet.org  or call 1-800-425-8361.

###

Contact: Jackie.Brinkman@ucdenver.edu

Share